Get latest articles and stories on Business at LatestLY. The first patient has been enrolled in the FDA IDE BTK (Below-the-Knee) SELUTION4BTK clinical trial involving SELUTION SLR™, MedAlliance s novel sirolimus-eluting balloon, just one week after receiving IDE approval. Business News | First Patient Enrolled in SELUTION SLR IDE BTK Study.
Several current and former residents of the initial reception centre in the Ermekeil barracks criticise the conditions in the accommodation. They complain of intimidation, being denied medical assistance and unequal conditions. The Cologne district government refers to the circumstances and rejects accusations.
LEIPZIG, Germany, June 8, 2022 /PRNewswire/ The first patient has been enrolled in the FDA IDE BTK (Below-the-Knee) SELUTION4BTK clinical trial involving SELUTION SLR, MedAlliance's novel